Last 12 months
Inside the activity.
0 purchase rows · 3 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 09, 2022 Filed Dec 13, 2022 18:15 UTC |
SANYAL SUNNYDirector · President and CEO
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 167,353 | $0.00 Strike: $22.13 | $0.00 |
DisclosureSEC source: 0001681622-22-000098 · wf-form4_167097333215461.xml · derivative · entry 1 SANYAL SUNNY · CIK 0001599398 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167,353 Underlying: Common Stock · 167,353 shares Expires 2032-12-09 F1 · derivative.exercise_date: These Performance Stock Options are subject to a four-year vesting schedule. 25% of the total number of options vest on December 10, 2023, and the remaining options vest monthly thereafter on the 10th day of each month on a pro rata basis. Read SEC document |
| December 09, 2022 Filed Dec 13, 2022 18:17 UTC |
Maheshwari ShubhamChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 19,756 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-22-000100 · wf-form4_167097338710016.xml · derivative · entry 2 Maheshwari Shubham · CIK 0001607969 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,756 Underlying: Common Stock · 19,756 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F3 · derivative.exercise_date: These Restricted Stock Units granted on December 9, 2022 vest 50% on December 10, 2024 and 50% on December 10, 2026. Vested shares will be delivered to the reporting person upon vest date. F3 · derivative.expiration_date: These Restricted Stock Units granted on December 9, 2022 vest 50% on December 10, 2024 and 50% on December 10, 2026. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| December 09, 2022 Filed Dec 13, 2022 18:17 UTC |
Maheshwari ShubhamChief Financial Officer
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 40,937 | $0.00 Strike: $22.13 | $0.00 |
DisclosureSEC source: 0001681622-22-000100 · wf-form4_167097338710016.xml · derivative · entry 1 Maheshwari Shubham · CIK 0001607969 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,937 Underlying: Common Stock · 40,937 shares Expires 2032-12-09 F1 · derivative.exercise_date: These Performance Stock Options are subject to a four-year vesting schedule. 25% of the total number of options vest on December 10, 2023, and the remaining options vest monthly thereafter on the 10th day of each month on a pro rata basis. Read SEC document |
| December 09, 2022 Filed Dec 13, 2022 23:15 UTC |
Hartmann AndrewSVP Sales & Marketing, Medical
|
GrantRestricted Stock Units · Derivative | 13,046 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-22-000097 · wf-form4_167097331413632.xml · derivative · entry 2 Hartmann Andrew · CIK 0001846805 · SVP Sales & Marketing, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,046 Underlying: Common Stock · 13,046 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F3 · derivative.exercise_date: These Restricted Stock Units granted on December 9, 2022 vest 50% on December 10, 2024 and 50% on December 10, 2026. Vested shares will be delivered to the reporting person upon vest date. F3 · derivative.expiration_date: These Restricted Stock Units granted on December 9, 2022 vest 50% on December 10, 2024 and 50% on December 10, 2026. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| December 09, 2022 Filed Dec 13, 2022 23:15 UTC |
Hartmann AndrewSVP Sales & Marketing, Medical
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 27,033 | $0.00 Strike: $22.13 | $0.00 |
DisclosureSEC source: 0001681622-22-000097 · wf-form4_167097331413632.xml · derivative · entry 1 Hartmann Andrew · CIK 0001846805 · SVP Sales & Marketing, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,033 Underlying: Common Stock · 27,033 shares Expires 2032-12-09 F1 · derivative.exercise_date: These Performance Stock Options are subject to a four-year vesting schedule. 25% of the total number of options vest on December 10, 2023, and the remaining options vest monthly thereafter on the 10th day of each month on a pro rata basis. Read SEC document |
| August 24, 2022 Filed Nov 9, 2022 19:00 UTC |
NAUMANN-ETIENNE RUEDIGERDirector
|
SaleCommon Stock | 5,000 | $21.60 | $108,000.00 |
DisclosureSEC source: 0001681622-22-000083 · wf-form4_166803838636960.xml · nonDerivative · entry 1 NAUMANN-ETIENNE RUEDIGER · CIK 0001219636 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,375 F1 · date: This Form 4 is being filed late due to an inadvertent administrative error. F2 · price: All individual shares were sold at a price of $21.60 Read SEC document |
| August 18, 2022 Filed Aug 22, 2022 17:05 UTC |
Honeysett Kimberley E.SVP and General Counsel
|
SaleCommon Stock | 3,028 | $23.50 | $71,158.00 |
DisclosureSEC source: 0001681622-22-000081 · wf-form4_166120232904706.xml · nonDerivative · entry 1 Honeysett Kimberley E. · CIK 0001695094 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,733 F1 · price: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on May 31, 2022. All shares were sold at $23.50 F2 · balance_after: Amount of securities beneficially owned at end of reporting period reflect 218 shares purchased under the Varex Imaging Corporation 2017 Employee Stock Purchase Plan. Read SEC document |
| August 18, 2022 Filed Aug 22, 2022 17:05 UTC |
Bardwell KathleenDirector
|
GrantDeferred Stock Units · Derivative | 3,619 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-22-000080 · wf-form4_166120230561881.xml · derivative · entry 1 Bardwell Kathleen · CIK 0001532367 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,619 Underlying: Common Stock · 3,619 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F2 · derivative.exercise_date: These Deferred Stock Units vest in full on the date of the next annual meeting (February 9, 2023) subject to the reporting person serving on the board of the company through the vesting date. Vested shares will be delivered to the reporting person upon the earlier of (i) 2025 annual meeting (ii) a change in control, (iii) the non-employee director termination of service for any reason. F2 · derivative.expiration_date: These Deferred Stock Units vest in full on the date of the next annual meeting (February 9, 2023) subject to the reporting person serving on the board of the company through the vesting date. Vested shares will be delivered to the reporting person upon the earlier of (i) 2025 annual meeting (ii) a change in control, (iii) the non-employee director termination of service for any reason. Read SEC document |
| August 15, 2022 Filed Aug 16, 2022 18:57 UTC |
Maheshwari ShubhamChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 30,315 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-22-000074 · wf-form4_166069063878185.xml · derivative · entry 3 Maheshwari Shubham · CIK 0001607969 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,315 Underlying: Common Stock · 30,315 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F4 · derivative.exercise_date: The Restricted Stock Units granted on October 2, 2020 vest 50% on August 15, 2022 and 50% on August 15, 2024. Vested shares will be delivered to the reporting person upon vest date. F4 · derivative.expiration_date: The Restricted Stock Units granted on October 2, 2020 vest 50% on August 15, 2022 and 50% on August 15, 2024. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| August 15, 2022 Filed Aug 16, 2022 18:57 UTC |
Maheshwari ShubhamChief Financial Officer
|
Tax withholdingCommon Stock | 7,640 | $22.31 | $170,448.40 |
DisclosureSEC source: 0001681622-22-000074 · wf-form4_166069063878185.xml · nonDerivative · entry 2 Maheshwari Shubham · CIK 0001607969 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,540 F3 · shares: These shares represent shares withheld for satisfaction of a tax withholding obligation arising as a result of the vesting of the Restricted Stock Units reported herein. Read SEC document |
| August 15, 2022 Filed Aug 16, 2022 18:57 UTC |
Maheshwari ShubhamChief Financial Officer
|
Exercise / conversionCommon Stock | 30,315 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001681622-22-000074 · wf-form4_166069063878185.xml · nonDerivative · entry 1 Maheshwari Shubham · CIK 0001607969 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,180 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F2 · balance_after: Amount of securities beneficially owned at end of reporting period reflect 3,865 shares purchased under the Varex Imaging Corporation 2017 Employee Stock Purchase Plan. Read SEC document |
| August 15, 2022 Filed Aug 16, 2022 22:57 UTC |
Hartmann AndrewSVP Sales & Marketing, Medical
|
Exercise / conversionRestricted Stock Units · Derivative | 1,638 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-22-000073 · wf-form4_166069061117432.xml · derivative · entry 3 Hartmann Andrew · CIK 0001846805 · SVP Sales & Marketing, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,638 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F3 · derivative.exercise_date: The Restricted Stock Units granted on August 24, 2018 vest 25% each year for four years beginning on August 15, 2019. Vested shares will be delivered to the reporting person upon vest date. F3 · derivative.expiration_date: The Restricted Stock Units granted on August 24, 2018 vest 25% each year for four years beginning on August 15, 2019. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| August 15, 2022 Filed Aug 16, 2022 22:57 UTC |
Hartmann AndrewSVP Sales & Marketing, Medical
|
Tax withholdingCommon Stock | 724 | $22.31 | $16,152.44 |
DisclosureSEC source: 0001681622-22-000073 · wf-form4_166069061117432.xml · nonDerivative · entry 2 Hartmann Andrew · CIK 0001846805 · SVP Sales & Marketing, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,059 F2 · shares: These shares represent shares withheld for satisfaction of a tax withholding obligation arising as a result of the vesting of the Restricted Stock Units reported herein. Read SEC document |
| August 15, 2022 Filed Aug 16, 2022 22:57 UTC |
Hartmann AndrewSVP Sales & Marketing, Medical
|
Exercise / conversionCommon Stock | 1,638 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001681622-22-000073 · wf-form4_166069061117432.xml · nonDerivative · entry 1 Hartmann Andrew · CIK 0001846805 · SVP Sales & Marketing, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,783 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| June 06, 2022 Filed Jun 8, 2022 17:30 UTC |
NAUMANN-ETIENNE RUEDIGERDirector
|
SaleCommon Stock | 5,207 | $22.62 | $117,782.34 |
DisclosureSEC source: 0001681622-22-000056 · wf-form4_165472378253949.xml · nonDerivative · entry 1 NAUMANN-ETIENNE RUEDIGER · CIK 0001219636 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,375 F1 · price: All individual shares were sold at a price of $22.62 Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 17:05 UTC |
Giambattista Brian WSVP and GM, X-ray Detectors
|
Exercise / conversionRestricted Stock Units · Derivative | 5,134 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-22-000041 · wf-form4_164513549620963.xml · derivative · entry 7 Giambattista Brian W · CIK 0001705559 · SVP and GM, X-ray Detectors 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,135 Underlying: Common Stock · 5,134 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F5 · derivative.exercise_date: The Restricted Stock Units granted on February 18, 2020 vest 50% on February 15, 2022 and 50% on February 15, 2024. Vested shares will be delivered to the reporting person upon vest date. F5 · derivative.expiration_date: The Restricted Stock Units granted on February 18, 2020 vest 50% on February 15, 2022 and 50% on February 15, 2024. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 17:05 UTC |
Giambattista Brian WSVP and GM, X-ray Detectors
|
Exercise / conversionRestricted Stock Units · Derivative | 1,420 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-22-000041 · wf-form4_164513549620963.xml · derivative · entry 6 Giambattista Brian W · CIK 0001705559 · SVP and GM, X-ray Detectors 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,420 Underlying: Common Stock · 1,420 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F4 · derivative.exercise_date: The Restricted Stock Units granted on February 15, 2019 vest 25% each year for four years beginning on February 15, 2020. Vested shares will be delivered to the reporting person upon vest date. F4 · derivative.expiration_date: The Restricted Stock Units granted on February 15, 2019 vest 25% each year for four years beginning on February 15, 2020. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 17:05 UTC |
Giambattista Brian WSVP and GM, X-ray Detectors
|
Exercise / conversionRestricted Stock Units · Derivative | 1,203 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-22-000041 · wf-form4_164513549620963.xml · derivative · entry 5 Giambattista Brian W · CIK 0001705559 · SVP and GM, X-ray Detectors 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,203 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F3 · derivative.exercise_date: The Restricted Stock Units granted on February 15, 2018 vest 25% each year for four years beginning on February 15, 2019. Vested shares will be delivered to the reporting person upon vest date. F3 · derivative.expiration_date: The Restricted Stock Units granted on February 15, 2018 vest 25% each year for four years beginning on February 15, 2019. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 17:05 UTC |
Giambattista Brian WSVP and GM, X-ray Detectors
|
Tax withholdingCommon Stock | 2,946 | $23.47 | $69,142.62 |
DisclosureSEC source: 0001681622-22-000041 · wf-form4_164513549620963.xml · nonDerivative · entry 4 Giambattista Brian W · CIK 0001705559 · SVP and GM, X-ray Detectors 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,922 F2 · shares: These shares represent shares withheld for satisfaction of a tax withholding obligation arising as a result of the vesting of the Restricted Stock Units reported herein. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 17:05 UTC |
Giambattista Brian WSVP and GM, X-ray Detectors
|
Exercise / conversionCommon Stock | 5,134 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001681622-22-000041 · wf-form4_164513549620963.xml · nonDerivative · entry 3 Giambattista Brian W · CIK 0001705559 · SVP and GM, X-ray Detectors 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,868 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 17:05 UTC |
Giambattista Brian WSVP and GM, X-ray Detectors
|
Exercise / conversionCommon Stock | 1,420 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001681622-22-000041 · wf-form4_164513549620963.xml · nonDerivative · entry 2 Giambattista Brian W · CIK 0001705559 · SVP and GM, X-ray Detectors 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,734 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 17:05 UTC |
Giambattista Brian WSVP and GM, X-ray Detectors
|
Exercise / conversionCommon Stock | 1,203 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001681622-22-000041 · wf-form4_164513549620963.xml · nonDerivative · entry 1 Giambattista Brian W · CIK 0001705559 · SVP and GM, X-ray Detectors 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,314 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 17:03 UTC |
Honeysett Kimberley E.SVP and General Counsel
|
Exercise / conversionRestricted Stock Units · Derivative | 5,086 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-22-000038 · wf-form4_164513540065444.xml · derivative · entry 8 Honeysett Kimberley E. · CIK 0001695094 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,086 Underlying: Common Stock · 5,086 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F6 · derivative.exercise_date: The Restricted Stock Units granted on February 18, 2020 vest 50% on February 15, 2022 and 50% on February 15, 2024. Vested shares will be delivered to the reporting person upon vest date. F6 · derivative.expiration_date: The Restricted Stock Units granted on February 18, 2020 vest 50% on February 15, 2022 and 50% on February 15, 2024. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 17:03 UTC |
Honeysett Kimberley E.SVP and General Counsel
|
Exercise / conversionRestricted Stock Units · Derivative | 1,397 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-22-000038 · wf-form4_164513540065444.xml · derivative · entry 7 Honeysett Kimberley E. · CIK 0001695094 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,397 Underlying: Common Stock · 1,397 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F5 · derivative.exercise_date: The Restricted Stock Units granted on February 15, 2019 vest 25% each year for four years beginning on February 15, 2020. Vested shares will be delivered to the reporting person upon vest date. F5 · derivative.expiration_date: The Restricted Stock Units granted on February 15, 2019 vest 25% each year for four years beginning on February 15, 2020. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 17:03 UTC |
Honeysett Kimberley E.SVP and General Counsel
|
Exercise / conversionRestricted Stock Units · Derivative | 1,104 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-22-000038 · wf-form4_164513540065444.xml · derivative · entry 6 Honeysett Kimberley E. · CIK 0001695094 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,104 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F4 · derivative.exercise_date: The Restricted Stock Units granted on February 15, 2018 vest 25% each year for four years beginning on February 15, 2019. Vested shares will be delivered to the reporting person upon vest date. F4 · derivative.expiration_date: The Restricted Stock Units granted on February 15, 2018 vest 25% each year for four years beginning on February 15, 2019. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 17:03 UTC |
Honeysett Kimberley E.SVP and General Counsel
|
Tax withholdingCommon Stock | 3,578 | $23.47 | $83,975.66 |
DisclosureSEC source: 0001681622-22-000038 · wf-form4_164513540065444.xml · nonDerivative · entry 4 Honeysett Kimberley E. · CIK 0001695094 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,543 F3 · shares: These shares represent shares withheld for satisfaction of a tax withholding obligation arising as a result of the vesting of the Restricted Stock Units reported herein. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 17:03 UTC |
Honeysett Kimberley E.SVP and General Counsel
|
Exercise / conversionCommon Stock | 5,086 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001681622-22-000038 · wf-form4_164513540065444.xml · nonDerivative · entry 3 Honeysett Kimberley E. · CIK 0001695094 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,121 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 17:03 UTC |
Honeysett Kimberley E.SVP and General Counsel
|
Exercise / conversionCommon Stock | 1,397 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001681622-22-000038 · wf-form4_164513540065444.xml · nonDerivative · entry 2 Honeysett Kimberley E. · CIK 0001695094 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,035 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 17:03 UTC |
Honeysett Kimberley E.SVP and General Counsel
|
Exercise / conversionCommon Stock | 1,104 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001681622-22-000038 · wf-form4_164513540065444.xml · nonDerivative · entry 1 Honeysett Kimberley E. · CIK 0001695094 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,638 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F2 · balance_after: Amount of securities beneficially owned at end of reporting period reflect 171 shares purchased under the Varex Imaging Corporation 2017 Employee Stock Purchase Plan. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 17:04 UTC |
Jonaitis Mark S.SVP and GM, X-Ray Sources
|
Exercise / conversionRestricted Stock Units · Derivative | 4,890 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-22-000039 · wf-form4_164513542789734.xml · derivative · entry 7 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,890 Underlying: Common Stock · 4,890 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F6 · derivative.exercise_date: The Restricted Stock Units granted on February 18, 2020 vest 50% on February 15, 2022 and 50% on February 15, 2024. Vested shares will be delivered to the reporting person upon vest date. F6 · derivative.expiration_date: The Restricted Stock Units granted on February 18, 2020 vest 50% on February 15, 2022 and 50% on February 15, 2024. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 17:04 UTC |
Jonaitis Mark S.SVP and GM, X-Ray Sources
|
Exercise / conversionRestricted Stock Units · Derivative | 1,354 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-22-000039 · wf-form4_164513542789734.xml · derivative · entry 6 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,354 Underlying: Common Stock · 1,354 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F5 · derivative.exercise_date: The Restricted Stock Units granted on February 15, 2019 vest 25% each year for four years beginning on February 15, 2020. Vested shares will be delivered to the reporting person upon vest date. F5 · derivative.expiration_date: The Restricted Stock Units granted on February 15, 2019 vest 25% each year for four years beginning on February 15, 2020. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 17:04 UTC |
Jonaitis Mark S.SVP and GM, X-Ray Sources
|
Exercise / conversionRestricted Stock Units · Derivative | 1,147 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-22-000039 · wf-form4_164513542789734.xml · derivative · entry 5 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,147 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F4 · derivative.exercise_date: The Restricted Stock Units granted on February 15, 2018 vest 25% each year for four years beginning on February 15, 2019. Vested shares will be delivered to the reporting person upon vest date. F4 · derivative.expiration_date: The Restricted Stock Units granted on February 15, 2018 vest 25% each year for four years beginning on February 15, 2019. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 17:04 UTC |
Jonaitis Mark S.SVP and GM, X-Ray Sources
|
Tax withholdingCommon Stock | 3,488 | $23.47 | $81,863.36 |
DisclosureSEC source: 0001681622-22-000039 · wf-form4_164513542789734.xml · nonDerivative · entry 4 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,463 F3 · shares: These shares represent shares withheld for satisfaction of a tax withholding obligation arising as a result of the vesting of the Restricted Stock Units reported herein. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 17:04 UTC |
Jonaitis Mark S.SVP and GM, X-Ray Sources
|
Exercise / conversionCommon Stock | 4,890 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001681622-22-000039 · wf-form4_164513542789734.xml · nonDerivative · entry 3 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,951 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 17:04 UTC |
Jonaitis Mark S.SVP and GM, X-Ray Sources
|
Exercise / conversionCommon Stock | 1,354 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001681622-22-000039 · wf-form4_164513542789734.xml · nonDerivative · entry 2 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,061 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 17:04 UTC |
Jonaitis Mark S.SVP and GM, X-Ray Sources
|
Exercise / conversionCommon Stock | 1,147 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001681622-22-000039 · wf-form4_164513542789734.xml · nonDerivative · entry 1 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,707 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F2 · balance_after: Amount of securities beneficially owned at end of reporting period reflect 2,185 shares purchased under the Varex Imaging Corporation 2017 Employee Stock Purchase Plan. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 17:04 UTC |
SANYAL SUNNYDirector · President and CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 30,223 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-22-000040 · wf-form4_164513545334263.xml · derivative · entry 7 SANYAL SUNNY · CIK 0001599398 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,223 Underlying: Common Stock · 30,223 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F5 · derivative.exercise_date: The Restricted Stock Units granted on February 18, 2020 vest 50% on February 15, 2022 and 50% on February 15, 2024. Vested shares will be delivered to the reporting person upon vest date. F5 · derivative.expiration_date: The Restricted Stock Units granted on February 18, 2020 vest 50% on February 15, 2022 and 50% on February 15, 2024. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 17:04 UTC |
SANYAL SUNNYDirector · President and CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 8,374 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-22-000040 · wf-form4_164513545334263.xml · derivative · entry 6 SANYAL SUNNY · CIK 0001599398 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,374 Underlying: Common Stock · 8,374 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F4 · derivative.exercise_date: The Restricted Stock Units granted on February 15, 2019 vest 25% each year for four years beginning on February 15, 2020. Vested shares will be delivered to the reporting person upon vest date. F4 · derivative.expiration_date: The Restricted Stock Units granted on February 15, 2019 vest 25% each year for four years beginning on February 15, 2020. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 17:04 UTC |
SANYAL SUNNYDirector · President and CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 7,092 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-22-000040 · wf-form4_164513545334263.xml · derivative · entry 5 SANYAL SUNNY · CIK 0001599398 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,092 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F3 · derivative.exercise_date: The Restricted Stock Units granted on February 15, 2018 vest 25% each year for four years beginning on February 15, 2019. Vested shares will be delivered to the reporting person upon vest date. F3 · derivative.expiration_date: The Restricted Stock Units granted on February 15, 2018 vest 25% each year for four years beginning on February 15, 2019. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 17:04 UTC |
SANYAL SUNNYDirector · President and CEO
|
Tax withholdingCommon Stock | 20,363 | $23.47 | $477,919.61 |
DisclosureSEC source: 0001681622-22-000040 · wf-form4_164513545334263.xml · nonDerivative · entry 4 SANYAL SUNNY · CIK 0001599398 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,952 F2 · shares: These shares represent shares withheld for satisfaction of a tax withholding obligation arising as a result of the vesting of the Restricted Stock Units reported herein. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 17:04 UTC |
SANYAL SUNNYDirector · President and CEO
|
Exercise / conversionCommon Stock | 30,223 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001681622-22-000040 · wf-form4_164513545334263.xml · nonDerivative · entry 3 SANYAL SUNNY · CIK 0001599398 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,315 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 17:04 UTC |
SANYAL SUNNYDirector · President and CEO
|
Exercise / conversionCommon Stock | 8,374 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001681622-22-000040 · wf-form4_164513545334263.xml · nonDerivative · entry 2 SANYAL SUNNY · CIK 0001599398 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,092 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 17:04 UTC |
SANYAL SUNNYDirector · President and CEO
|
Exercise / conversionCommon Stock | 7,092 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001681622-22-000040 · wf-form4_164513545334263.xml · nonDerivative · entry 1 SANYAL SUNNY · CIK 0001599398 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,718 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 22:06 UTC |
Hartmann AndrewSVP Sales & Marketing, Medical
|
Exercise / conversionRestricted Stock Units · Derivative | 5,134 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-22-000042 · wf-form4_164513555572277.xml · derivative · entry 5 Hartmann Andrew · CIK 0001846805 · SVP Sales & Marketing, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,135 Underlying: Common Stock · 5,134 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F4 · derivative.exercise_date: The Restricted Stock Units granted on February 18, 2020 vest 50% on February 15, 2022 and 50% on February 15, 2024. Vested shares will be delivered to the reporting person upon vest date. F4 · derivative.expiration_date: The Restricted Stock Units granted on February 18, 2020 vest 50% on February 15, 2022 and 50% on February 15, 2024. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 22:06 UTC |
Hartmann AndrewSVP Sales & Marketing, Medical
|
Exercise / conversionRestricted Stock Units · Derivative | 1,623 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-22-000042 · wf-form4_164513555572277.xml · derivative · entry 4 Hartmann Andrew · CIK 0001846805 · SVP Sales & Marketing, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,623 Underlying: Common Stock · 1,623 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F3 · derivative.exercise_date: The Restricted Stock Units granted on February 15, 2019 vest 25% each year for four years beginning on February 15, 2020. Vested shares will be delivered to the reporting person upon vest date. F3 · derivative.expiration_date: The Restricted Stock Units granted on February 15, 2019 vest 25% each year for four years beginning on February 15, 2020. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 22:06 UTC |
Hartmann AndrewSVP Sales & Marketing, Medical
|
Tax withholdingCommon Stock | 3,206 | $23.47 | $75,244.82 |
DisclosureSEC source: 0001681622-22-000042 · wf-form4_164513555572277.xml · nonDerivative · entry 3 Hartmann Andrew · CIK 0001846805 · SVP Sales & Marketing, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,145 F2 · shares: These shares represent shares withheld for satisfaction of a tax withholding obligation arising as a result of the vesting of the Restricted Stock Units reported herein. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 22:06 UTC |
Hartmann AndrewSVP Sales & Marketing, Medical
|
Exercise / conversionCommon Stock | 5,134 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001681622-22-000042 · wf-form4_164513555572277.xml · nonDerivative · entry 2 Hartmann Andrew · CIK 0001846805 · SVP Sales & Marketing, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,351 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 22:06 UTC |
Hartmann AndrewSVP Sales & Marketing, Medical
|
Exercise / conversionCommon Stock | 1,623 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001681622-22-000042 · wf-form4_164513555572277.xml · nonDerivative · entry 1 Hartmann Andrew · CIK 0001846805 · SVP Sales & Marketing, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,217 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| February 14, 2022 Filed Feb 15, 2022 00:16 UTC |
TSINGOS CHRISTINE ADirector
|
Exercise / conversionDeferred Stock Units · Derivative | 5,098 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-22-000022 · wf-form4_164488415846600.xml · derivative · entry 3 TSINGOS CHRISTINE A · CIK 0001278861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,098 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F3 · derivative.exercise_date: These Deferred Stock Units vested on February 14, 2020. Pursuant to the terms of the applicable grant agreement, delivery of the vested Deferred Stock Units, in the form of common stock, was made on February 14, 2022. F3 · derivative.expiration_date: These Deferred Stock Units vested on February 14, 2020. Pursuant to the terms of the applicable grant agreement, delivery of the vested Deferred Stock Units, in the form of common stock, was made on February 14, 2022. Read SEC document |
| February 14, 2022 Filed Feb 15, 2022 00:16 UTC |
TSINGOS CHRISTINE ADirector
|
Exercise / conversionCommon Stock | 5,098 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001681622-22-000022 · wf-form4_164488415846600.xml · nonDerivative · entry 1 TSINGOS CHRISTINE A · CIK 0001278861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,558 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.